PRESS RELEASE published on 11/01/2023 at 10:00, 3 years ago iOmx Therapeutics attends upcoming scientific and industry conferences
PRESS RELEASE published on 09/05/2023 at 08:30, 3 years 2 months ago iOmx Therapeutics appoints Dr. Nils Peter Debus as Chief Business Officer
PRESS RELEASE published on 04/04/2023 at 10:00, 3 years 7 months ago iOmx Therapeutics Announces Dosing of First Patient with SIK Inhibitor OMX-0407 in Phase I Clinical Trial
PRESS RELEASE published on 02/23/2023 at 10:00, 3 years 8 months ago iOmx Therapeutics appoints Dr. Christine Rothe as new Chief Development Officer
Published on 11/10/2026 at 02:45, 2 hours 8 minutes ago Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:10, 5 hours 43 minutes ago Ur-Energy Reports Third Quarter 2026 Results
Published on 11/09/2026 at 23:00, 5 hours 53 minutes ago LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 6 hours 21 minutes ago Announces Extension for Closing of Private Placement of Convertible Promissory Notes
Published on 11/09/2026 at 22:15, 6 hours 38 minutes ago Goldcliff Announces Closing of the Second and Final Tranche of its "LIFE" Offering and Completion of Drilling at Kettle Valley
Published on 11/10/2026 at 01:20, 3 hours 33 minutes ago US defence customer steps up orders and first graphene oxide orders secured
Published on 11/09/2026 at 22:54, 5 hours 59 minutes ago EQS-Adhoc: Northern Data Group reports Q3 2026 and raises its FY 2026 revenue outlook communicated on 17 June 2026
Published on 11/09/2026 at 22:10, 6 hours 43 minutes ago Quantinuum to Participate in the Cantor Convergence 4th Annual Crypto, FinTech, AI & Energy Infrastructure Conference
Published on 11/09/2026 at 22:05, 6 hours 48 minutes ago Mayr-Melnhof Karton AG: MM Group to sell majority stake in its Packaging business to KPS Capital Partners and plans a special distribution to shareholders
Published on 11/09/2026 at 18:30, 10 hours 23 minutes ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 17:35, 11 hours 18 minutes ago Disclosure of transactions in own shares from November 2 to November 6, 2026
Published on 11/09/2026 at 10:32, 18 hours 21 minutes ago Disclosure of shares outstanding and voting rights - 09.11.2026
Published on 11/09/2026 at 07:00, 21 hours 53 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
